SV

Street Verdict

Analyst Scorecard

A record of what Ankush Bajaj said publicly, with the source. Not advice.

“Bullish on Glaxo, recommending a buy at ₹2,638 with targets of ₹2725-2750 and a stop loss at ₹2,544. The stock shows bullish momentum on the daily timeframe and has formed a clear double bottom around the 2460 level on the hourly chart, making it a good candidate for a long trade.”

Ankush Bajaj’s track record (trackable calls only): 473 graded calls · 95% CI 39–48%

GlaxoSmithKline Pharmaceuticals Ltd.BullishCalled 25 Feb 2025Graded 18 Mar 2025
Verdict:HIT

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Entry: ₹2,638, as stated.

Target ₹2,725, stop ₹2,544, as stated.

No time frame is stated, so it is tracked until a close reaches ₹2,725 or ₹2,544: there is no fixed window.

The target ₹2,725 was reached on a close before the stop ₹2,544. Hit.

The grader’s working: R3 TRADE_SETUP: entered ₹2683.3 on 2025-03-07 (stated entry ₹2638, BREAKOUT entry, filled); target ₹2725 reached at close ₹2725.8 on 2025-03-18. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Tracking GlaxoSmithKline Pharmaceuticals Ltd. since this call

1-year tracking window
Read the original articleSee Ankush Bajaj’s full track record